Solid-state Chemistry Services CRO, Onyx Scientific Reports Increased Demand for Polymorph Screening, Salt Selection and Crystallization Studies
Onyx delivers 'one partner' convenience with pre-agreed workflows tailored to support key analytical milestones and timescales.
View as PDF
November 10, 2010 (FPRC) -- Experts in the provision of solid-state chemistry services for the pharmaceutical and biotech industries, leading global contract research organisation, Onyx Scientific, is delighted to report increased demand in taking candidate compounds from concept through to process development and scale-up of APIs for Phase I and Phase II clinical studies.
'Handling difficult-to-crystallize materials is an art form as well as a science' explains Tony Flinn, CEO, Onyx Scientific. 'Inherently complicated, the implications of a well-designed crystallization process are considerable and it requires exceptional scientific knowledge to reliably isolate products in a crystalline phase. Through diverse chemistry expertise we take candidate compounds through all stages of solid-form characterization, salt selection, co-crystal and polymorph screening in the challenge to develop optimum crystal forms'.
'Equally, in the world of polymorphs, confusing results come as standard' explains Tony. 'Our high-throughput polymorph screening platform requires just milligram amounts of target material to evaluate APIs for polymorphisms'.
Tony adds, 'The demand for our solid-state contract chemistry services has never been stronger'.
Onyx solid-state chemistry services typically include:
* Polymorph, salt, and co-crystal screening and investigation
* Amorphous content and stability investigations
* Physico-chemical characterization and selection of the optimal solid form
* Crystallization screening and process optimization
As ‘preferred supplier’ to four of the world’s top seven pharmaceutical companies, Onyx also enjoys repeat business with more than 150 companies worldwide.
MHRA certified, Onyx Scientifics’ state-of-the-art facility conforms to international GMP standards for the development and production of active pharmaceutical ingredients.
Send an email to Sue Jones of Onyx Scientfic Ltd
+44 (0) 191 516 6516
Recent Press Releases By The Same User
Gmp Synthesis Chemistry Services Organisation, Onyx Scientific, Announce Increased Demand for Early-phase Investigational New Drug (IND) Development (Wed 23rd Mar 11)
Custom Synthesis Chemistry Services CRO, Onyx Scientific, Hails the Success of Its Solid-state Polymorph Screening Services (Tue 28th Dec 10)
Gmp Synthesis Chemistry Services CRO, Onyx Scientific, Reports Increased Small Scale Production for Phase I and II Clinical Studies (Fri 3rd Sep 10)
Polymorph Screening Chemistry Services CRO, Onyx Scientific, Announces the Continued Strong Growth of Its Solid-state Services (Tue 6th Jul 10)
Onyx Scientific Grows API GMP Synthesis Contract Chemistry Services (Fri 9th Apr 10)